Risks and Benefits of Continuing Renin-Angiotensin-Aldosterone System Inhibitors in Critically-Ill Patients

被引：0

作者：

Chou, Ruey-Hsing ^{[1
,2
,3
,4
]}

Yang, Shang-Feng ^{[4
,5
]}

Huang, Po-Hsun ^{[2
,4
,6
]}

机构：

[1] Natl Yang Ming Chiao Tung Univ, Dept Crit Care Med, Hsinchu, Taiwan

[2] Natl Yang Ming Chiao Tung Univ, Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Hsinchu, Taiwan

[3] Natl Yang Ming Chiao Tung Univ, Cardiovasc Res Ctr, Hsinchu, Taiwan

[4] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Hsinchu, Taiwan

[5] Cheng Hsin Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan

[6] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Med, Taipei, Taiwan

来源：

ACTA CARDIOLOGICA SINICA | 2024年 / 40卷 / 02期

关键词：

ACEi; angiotensin-converting enzyme inhibitor; AKI; acute kidney injury; ARB; angiotensin receptor blocker; eGFR; estimated; glomerular filtration rate; ICU; intensive care unit;

D O I：

10.6515/ACS.202403_40(2).20231206B

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We read with interest the letter by Ali Coner et al. responding to our previously published article.1 Dr. Coner suggested drug administration in intensive care units (ICU) should be arranged based on hemodynamic status. They requested us to compare patients who continued renin-angiotensin-aldosterone system (RAAS) inhibitors during ICU stay and those who withdrew in terms of clinical outcome. They also suggested we provide the reasons for withdrawing RAAS inhibitors. Because our institution did not have a standardized protocol guiding

引用

页码：260 / 261

页数：2

共 50 条

[1] ALTERATIONS IN THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN THE CRITICALLY ILL
LUGER, A
GRAF, H
PRAGER, R
STUMMVOLL, HK
HORMONE AND METABOLIC RESEARCH, 1984, 16 (04) : 213 - 214
[2] Inhibitors of the renin-angiotensin-aldosterone system and COVID-19 in critically ill elderly patients
Jung, Christian
Bruno, Raphael Romano
Wernly, Bernhard
Joannidis, Michael
Oeyen, Sandra
Zafeiridis, Tilemachos
Marsh, Brian
Andersen, Finn H.
Moreno, Rui
Fernandes, Ana Margarida
Artigas, Antonio
Pinto, Bernardo Bollen
Schefold, Joerg
Wolff, Georg
Kelm, Malte
De Lange, Dylan W.
Guidet, Bertrand
Flaatten, Hans
Fjolner, Jesper
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (01) : 76 - 77
[3] Why the renin-angiotensin-aldosterone system (RAAS) in critically ill patients can no longer be ignored
Zarbock, Alexander
Chawla, Lakhmir
Bellomo, Rinaldo
CRITICAL CARE, 2021, 25 (01)
[4] Hyperkalemia and inhibitors of the renin-angiotensin-aldosterone system
Segal, A
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (23): : 2450 - 2451
[5] Calcineurin inhibitors and the renin-angiotensin-aldosterone system
Berber, Mesut
Penton, David
ACTA PHYSIOLOGICA, 2024, 240 (12)
[6] Renin-Angiotensin-Aldosterone System Inhibitors in Heart Failure
Shearer, F.
Lang, C. C.
Struthers, A. D.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (04) : 459 - 467
[7] Potassium Homeostasis and Renin-Angiotensin-Aldosterone System Inhibitors
Weir, Matthew R.
Rolfe, Mark
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (03): : 531 - 548
[8] Hyperkalemia and inhibitors of the renin-angiotensin-aldosterone system - Reply
Palmer, BF
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (23): : 2451 - 2451
[9] Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Vaduganathan, Muthiah
Vardeny, Orly
Michel, Thomas
McMurray, John J., V
Pfeffer, Marc A.
Solomon, Scott D.
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (17): : 1653 - 1659
[10] Renin-Angiotensin-Aldosterone System Blockade in Critically Ill Patients Is Associated with Increased Risk for Acute Kidney Injury
Lim, Hye Jin
Lee, Hyun Hee
Kim, Ae Jin
Ro, Han
Kim, Hyung Soo
Chang, Jae Hyun
Chung, Wookyung
Jung, Ji Yong
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 238 (01): : 17 - 23

← 1 2 3 4 5 →